D van den Boom - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

D van den Boom

Showing results (21-30 of 22) with videos related to

Pageof 3

Sort By:

You have reached the last page of results.This site can display upto 22 results.

Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008

TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activationMoniek A de Witte, Gavin M Bendle, Marly D van den Boom, et al.

Prenatal Diagnosis|October 28, 2015

Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13J A Tynan, S K Kim, A R Mazloom, et al.

Pageof 3

Search research articles

Showing results (21-30 of 22) with videos related to

Sort By:

Pageof 3

You have reached the last page of results.This site can display upto 22 results.

Journal of Immunology (Baltimore, Md. : 1950)|August 8, 2008

TCR gene therapy of spontaneous prostate carcinoma requires in vivo T cell activationMoniek A de Witte, Gavin M Bendle, Marly D van den Boom, et al.

Prenatal Diagnosis|October 28, 2015

Application of risk score analysis to low-coverage whole genome sequencing data for the noninvasive detection of trisomy 21, trisomy 18, and trisomy 13J A Tynan, S K Kim, A R Mazloom, et al.

Pageof 3